跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Norisan - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Norisan
Approved
STANDARD
Norisan
Mackur Laboratories Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b2763ecef4c41e44
Company
Mackur Laboratories Limited
Type
Standard
Approval Details
Approval Id
b2763ecef4c41e44
Drug Approval Philippines Name
Norisan
Product Name
Norisan
Registration Number
DRP-10929-14
Brand Name
Norisan
Generic Name
Norepinephrine (As Bitartrate)
Dosage Form
Solution For Injection (IV)
Dosage Strength
1mg/mL (4mg/4mL)
Manufacturer
Mackur Laboratories Limited
Distributor
Sanimed Pharmaceuticals Inc.
Issuance Date
29 July 2022
Expiry Date
31 January 2027
Pharmacologic Category
Adrenergic/Dopaminergic Agent
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b2763ecef4c41e44
Type
Standard
Back to Philippines FDA Approvals